Association of nonsense mutation of dystrophin gene with disruption of sarcoglycan complex in X-linked dilated cardiomyopathy

Lancet

Volumn 355, Issue 9217, 2000, Pages 1781-1785

  Franz, Wolfgang Michael ^a   Müller, Matthias ^a   Müller, J Oliver ^a   Herrmann, Ralf ^b   Rothmann, Thomas ^c   Cremer, Marion ^d   Cohn, Ronald D ^b   Voit, Thomas ^b   Katus, Hugo A ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; EPITOPE; SARCOGLYCAN;

ALTERNATIVE RNA SPLICING; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; EXON; FAMILY STUDY; HEART MUSCLE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NONSENSE MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SARCOLEMMA; SINGLE STRAND CONFORMATION POLYMORPHISM; SKELETAL MUSCLE; WESTERN BLOTTING;

EID: 0343963762     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02266-2     Document Type: Article

References (34)

1. England S.B., Nicholson L.V., Johnson M.A.et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med. 326:1992;77-82.
2. Grünig E., Tasman J.A., Kücherer H., Franz W.M., Kübler H.A. Frequency of phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol. 31:1998;186-194.
3. Towbin J.A., Hejtmancik J.F., Brink P., et al X. linked dilated cardiomyopathy. molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus Circulation. 87:1993;1854-1865.
4. Olson T., Michels V., Thibodeau S., Tai Y., Keating M. Actin mutations in dilated cardiomyopathy. a heritable form of heart failure Science. 280:1998;750-752.
5. Beggs A.H. Dystrophinopathy, the expanding phenotype - dystrophin abnormalities in X-linked dilated cardiomyopathy. Circulation. 95:1997;2344-2347.
6. Hunsaker R.H., Fulkerson P.K., Barry F.J., Lewis R.P., Leier C.V., Unverferth D.V. Cardiac function in Duchenne's muscular dystrophy. result of 10-year follow-up study and nonivasive test Am J Med. 73:1982;235-238.
7. Melacini P., Fanin M., Danieli G.A.et al. Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy. Circulation. 94:1996;3168-3175.
8. Muntoni F., Cau M., Ganau A.et al. Brief report. deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy N Engl J Med. 329:1993;921-925.
9. Franz W.M., Cremer M., Herrmann R., et al X. linked dilated cardiomyopathy. novel mutation of the dystrophin gene Ann N Y Acad Sci. 752:1995;470-491.
10. Yoshida K., Ikeda S., Nakamura A.et al. Molecular analysis of the Duchenne muscular dystrophy gene in patients with Becker muscular dystrophy presenting with dilated cardiomyopathy. Muscle Nerve. 16:1993;1161-1166.
11. Ferlini A., Nazzareno G., Merlini L., Sewry C., Branzi A., Muntoni F. A novel Alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy. Am J Hum Genet. 63:1998;436-446.
12. Bies R.D., Maeda M., Roberds S.L.et al. A 5′ dystrophin duplication mutation causes membrane deficiency of alpha-dystroglycan in a family with X-linked cardiomyopathy. J Mol Cell Cardiol. 29:1997;3175-3188.
13. Muntoni F., Wilson L., Marrosu G.et al. A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart. J Clin Invest. 96:1995;693-699.
14. Ortiz-Opez R., Li H., Su J., Goytia V., Towbin J.A. Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. Circulation. 95:1997;2434-2440.
15. Campbell K.P. Three muscular dystophies. loss of cytoskeleton-extracellular matrix linkage Cell. 80:1995;675-679.
16. Fadic R., Sunada Y., Walclawik A.J.et al. Brief report. deficiency of a dystrophin-associated glycoprotein (adhalin) in a patient with muscular dystrophy and cardiomyopathy N Engl J Med. 334:1996;362-366.
17. Nigro V., Piluso G., Belsito A.et al. Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein. Hum Mol Genet. 5:1996;1179-1186.
18. Nigro V., Okazaki Y., Belsito A.et al. Identification of the syrian hamster cardiomyopathy gene. Hum Mol Genet. 6:1997;601-607.
19. Koenig M., Hoffman E.P., Bertelson C.J., Monaco A.P., Feener C.A., Kunkel L.M. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell. 50:1987;509-517.
20. Lim L.E., Duclos F., Broux O.et al. Beta-sarcoglycan. characterization and role in limb-girdle muscular dystrophy linked to 4q12 Nat Genet. 11:1995;257-265.
21. Jung D., Duclos F., Apostal B.et al. Characterization of delta-sarcoglycan, a novel component of the oligomeric sarcoglycan complex involved in limb-girdle muscular dystrophy. J Biol Chem. 271:1996;32321-32329.
22. Voit T., Patel K., Dunn M.J., Dubowitz V., Strong P.N. Distribution of dystrophin, neblin and Ricinus communis I(RCA-I)-binding glycoprotein in tissues of normal and mdx mice. J Neurol Sci. 89:1989;199-211.
23. Prior T.W., Bartolo C., Pearl D.K.et al. Spectrum of small mutations in the dystrophin coding region. Am J Hum Genet. 57:1995;22-23.
24. Shiga N., Takeshima Y., Sakamoto H.et al. Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy. J Clin Invest. 100:1997;2204-2210.
25. Watakabe A., Tanaka K., Shimura Y. The role of exon sequences in splice site selection. Genes Dev. 7:1993;407-418.
26. Rybakova I.N., Amann K.J., Ervasti J.M. A new model for the interaction of dystrophin with F-actin. J Cell Biol. 135:1996;661-672.
27. England S.B., Nicholson L.V., Johnson M.A.et al. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature. 343:1990;180-182.
28. Koenig M., Kunkel L.M. Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. J Biol Chem. 256:1990;4560-4566.
29. Palek J., Lambert S. Genetics of the red cell membrane skeleton. Semin Hematol. 27:1990;290-332.
30. Chan Y., BÖnnemann C.G., Lidow H.G.W., Kunkel L.M. Molecular organization of sarcoglycan complex in mouse myotubes in culture. J Biol Chem. 143:1998;2033-2044.
31. Meng H., Leddy J.J., Frank J., Holland P., Tuana B.S. The association of cardiac dystrophin with myofibrils/z-discs regions in cardiac muscle suggests a novel role in the contractile apparatus. J Biol Chem. 271:1996;12364-12371.
32. Stevenson S., Rothery S., Cullen M.J., Severs N.J. Dystrophin is not a specific component of the costamere. Circ Res. 80:1997;269-280.
33. Bies R.D., Maeda M., Roberds S.L.et al. A 5′ Dystrophin duplication mutation causes membrane deficiency of alpha-dystroglycan in a family with X-linked cardiomyopathy. Mol Cell Cardiol. 29:1997;3175-3188.
34. Badorff C., Lee G.H., Lamphear B.J.et al. Enteroviral protease 2A cleaves dystrophin. evidence of cytoskeletal disruption in an acquired cardiomyopathy Nat Med. 5:1999;320-326.